相关实验视频

Updated: Jul 13, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

在血液性恶性瘤中对AlphaMissense预测的现实生活评估

Kaddour Chabane¹, Carole Charlot¹, Dan Gugenheim

¹Hospices Civils de Lyon, Hôpital Lyon Sud, Service d'hématologie biologique, Pierre Bénite, France.

|December 22, 2023

概括

AlphaMissense准确地预测了血液恶性瘤中的误解突变效应. 这种机器学习工具增强了用于临床应用的诊断解释.

科学领域:

基因组学就是基因组学.
生物信息学是一种生物信息学.
计算生物学计算生物学

背景情况:

高通量测序对于诊断血液恶性瘤至关重要.
解释误解突变是一个重大的诊断挑战.
机器学习为变体解释提供了潜在的解决方案.

研究的目的:

评估AlphaMissense数据库在预测误解突变效应方面的有效性.
评估AlphaMissense对改善血液恶性瘤诊断解释的影响.
分析AlphaMissense预测与当前临床解释之间的差异.

主要方法:

利用AlphaMissense数据库进行变种预测.
从686名接受临床分析的患者中分析了2073种变异.
使用接收器操作特征曲线 (AUC) 下的面积评估预测准确性.

主要成果:

在一个大型的真实数据集上,AlphaMissense表现出非常高的预测准确性 (AUC为0.95).
在临床环境中证实了AlphaMissense的实用性.
详细分析了AlphaMissense预测和现有的临床解释之间的差异.

结论:

AlphaMissense是一种非常准确的工具,用于预测血液恶性瘤中的错误感应突变效应.
该数据库有助于对遗传变异的临床解释.
对差异的进一步分析可以完善诊断策略.

更多相关视频

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

相关概念视频

Non-LTR Retrotransposons

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...